Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone emphasizes excitement and acknowledgment of the study's importance, exemplified by comments calling it a 'huge' breakthrough and noting its potential to change PTSD treatment. Discussions include references to specific results, such as the reduction of PTSD severity and the potential for FDA approval, which illustrate users' deep engagement with the research's significance and details.
Most discussions strongly support the findings, highlighting the therapy's efficacy and safety based on the positive trial results, indicating broad agreement.
Many comments express high interest, with phrases like 'Huge news' and 'Potential breakthrough' reflecting enthusiasm and curiosity about the implications.
Responses reference detailed trial outcomes, such as the 67% of participants no longer qualifying for PTSD, showing deep engagement with the study's data and implications.
The recurring use of words like 'Huge,' 'Breakthrough,' and 'Merits expedited evaluation' demonstrate a perception that this research could significantly influence mental health treatments and policy.
興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assisted therapy for severe PTSD https://t.co/R0DH1wTrlF
重度のPTSD患者に対するサイケデリック療法 としてのMDMA支援療法の有効性、安全性を調べた第III相二重盲検比較試験によれば、MDMA支援療法はトラウマやうつ気分などの病状の改善に有効かつ、暴力のリスクや自殺、その他の有害事象とも関連しなかったそうだ Nat Med (2021). https://t.co/R0DH1wSTw7
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/iNMUF6kSMv
In this video, we explore how #phenethylamines such as #MDMA and #methamphetamine bind to transporter #proteins such as #serotonin transporter protein. https://t.co/N9TXxFBOpg #drugdesign #drugdiscovery #structuralbiology #medchem #compchem #virtualreality #vr #molecularbiology https://t.co/sk5VSAvgrx
#Research reading: MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study https://t.co/1j4uBGW3og
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/TtD2RA2A5X
MDMA, also known as Ecstasy or Molly, is nearing FDA approval for treating PTSD. This video explores how MDMA-assisted therapy significantly reduces symptoms and enhances functioning in severe cases, based on recent…
We present to you biggest research breakthroughs in Science particularly chemistry and drug discovery in the year 2021. The major one being the predictive ability of Alphafold, skeletal editing, MDMA trials, recyclable…
Here we explore how phenethylamines such as MDMA and methamphetamine bind to transporter proteins using VR. MDMA-assisted therapy shows promise as an effective treatment for severe PTSD, with clinical trials indicating…
PTSD is a significant public health issue, and current treatments have limited effectiveness. A recent clinical trial explored MDMA-assisted therapy for severe PTSD, showing significant symptom reduction and safety for…
MDMA also known as Ecstasy or Molly is close to FDA approval for PTSD treatment. This video discusses its use in therapy. In a phase 3 trial, MDMA-assisted therapy significantly reduced PTSD symptoms and functional…
MDMA, also known as Ecstasy or Molly, is close to gaining FDA approval for PTSD treatment. It alters emotional processing and facilitates positive social interaction, potentially supporting therapeutic outcomes without…
The episode discusses my experience with plant medicine in Costa Rica, focusing on its potential therapeutic use and the importance of ongoing research to reclassify these substances. It highlights emerging treatments…
Join Stella from Sweden as she delves into the fascinating world of MDMA exploring its origins its rise in therapeutic use and its profound impact on culture Discover the science behind its healing powers and what the…
Psychedelics and mental health Ever wondered how those mindbending substances you've heard about actually work on your brain. This video explores how psychedelics can alter perception, mood, and their potential in…
RT @ichiipsy: 重度のPTSD患者に対するサイケデリック療法 としてのMDMA支援療法の有効性、安全性を調べた第III相二重盲検比較試験によれば、MDMA支援療法はトラウマやうつ気分などの病状の改善に有効かつ、暴力のリスクや自殺、その他の有害事象とも関連しなかったそ…
For clarification: The 2021 paper MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study was NOT retracted. All papers retracted involved phase 2 trials. Reference: https://t.co/OxNw507bsu
https://t.co/5nfgqngFsO
[1] Mitchell, J.M., Bogenschutz, M., Lilienstein, A. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med 27, 1025–1033 (2021). https://t.co/2gDgJ7suKg
@todayisthedayf2 https://t.co/vXReGBd0x6
@ScottAdamsSays https://t.co/NumRey1VFI
RT @takatoh_life: 【原著論文 (1/2)】 Mitchell, JM, et al. "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled…
【原著論文 (1/2)】 Mitchell, JM, et al. "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study" Nat Med 27, 1025–1033 Pub 10 May 2021 https://t.co/LjdhmwXSSK
@NotSoProf0und https://t.co/yClMZvcLTV https://t.co/AGArz6Jtm3
Обмеженість кількості досліджень. Якщо ми звернемось до UpToDate то вони пропонують 2 свіжих рандомізованих дослідження. Але є нюанс. Конфлікт інтересів в кожному з них це цілий список. https://t.co/lDUL0qDUhq https://t.co/FeeYM4PcUD https://t.co/JYLwmnyzyu
RT @Liberator369: https://t.co/lZtbTGBl3F
https://t.co/lZtbTGBl3F
https://t.co/9AYdW900c7
@Yes_view ну вообще есть исследования на тему эффективности личной терапии, но мало, все-таки это нелегально в большинстве случаев (https://t.co/5rLkNC52OJ)
@arstechnica MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/2jMsFl6Evu
RT @TheEinarkist: @Rainmaker1973 MDMA looks to be highly efficacious for people with severe PTSD if used in a clinical setting https://t…
#Research reading: MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study https://t.co/1j4uBGW3og
The first, (May 2021), "Nature Medicine" paper the above "Nature" article is based upon, & links to: “MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study” 2/3 https://t.co/w5uupwgBhn
RT @FWolswijk: The reduction in the CAPS-5 score (a common measure of PTSD) is very similar to the Phase IIIa study (-24.4) https://t.co/y…
The reduction in the CAPS-5 score (a common measure of PTSD) is very similar to the Phase IIIa study (-24.4) https://t.co/yduii5L1TF Still, something to analyse more deeply, the treatment effect of the placebo (+therapy) group is also very strong https://t.co/gy8PaNZT6t
"MDMA-assisted therapy is highly efficacious in individuals with severe PTSD, and treatment is safe and well-tolerated, even in those with comorbidities." [May 2021] https://t.co/F28tnm6i1j https://t.co/WHqL8q7whm
@gummatt https://t.co/1Z7NLNL3XW https://t.co/V74a2VNzPe
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/AQghAAhSLc
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study https://t.co/1i6ySGeraG https://t.co/vah13HlE3F
Ecstasy (Molly) for Trauma? - Yep It’s Coming Soon https://t.co/Y8Eem81wqQ via @YouTube
The 10/15/2021 #JournalClub presented "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study". The recording is available free to all AAPP members. https://t.co/HIl0tFbeZ7 https://t.co/hsrEv6HsZm
@1tsS4r @cremieuxrecueil I don't follow closely but the most promising things I've seen are psychedelics and other "recreational" drugs. MDMA, psilocybin, ketamine, & related. There's an impressive phase 3 trial of MDMA for PTSD; probably going to be FDA approved in 2024. https://t.co/SzfCfjsbni
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/FMJBmeFU7U
Ever explored these mechanisms in #VR? We have!
This re-analysis investigates measures of self-experience by participants from the MAPS Phase III trial (of which just now the 2nd half was completed) https://t.co/RDjgU5jyLk 2/7
https://t.co/9vAnYTjuIy
@KatrinPreller FYSA: https://t.co/cM7r7oyFjI Promising results are being had using MDMA (linked article) in conjunction with psilocybin/ ayahuasca
Because Seratonin reuptake does not work. all anti-depressant is a scams by pharmaceutical companies. Ecstasy (Molly) for Trauma? - Yep It’s Coming Soon https://t.co/ACEbMy3KQl via @YouTube
https://t.co/ytR7Rvc2dC
Ecstasy (Molly) for Trauma? - Yep It’s Coming Soon https://t.co/CFMKE8yYwj via @YouTube
(Rick continues with the Phase IIIa data - but the MAPSBC slides also don't like to be shared
For (much) more about the Phase III(a) study see below
@MAPSPBC Most reading/listening along probably know a lot about MDMA-assisted therapy (-AT) To learn more, see the reporting by MAPS https://t.co/RDjgU5j0VM https://t.co/jfxjAM4XA2
The 10/15/2021 #JournalClub presented "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study". The recording is available free to all CPNP members. https://t.co/eCSYE6uoxj https://t.co/gIKJULn4Zy
@therealbrom https://t.co/j28gT7qkmp + https://t.co/14pr2s6aME
RT @ichiipsy: 興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assis…
RT @ichiipsy: 興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assis…
RT @ichiipsy: 興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assis…
RT @ichiipsy: 興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assis…
RT @ichiipsy: 興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assis…
RT @ichiipsy: 興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assis…
興味深いことに、重度のトラウマに悩むPTSDの人ではアンフェタミン誘導体であるMDMAを補助的に用いた心理療法が有効とも考えられていて、MDMAによって「耐性の窓」を維持したまま、トラウマの克服が行えている可能性もあるそうだ。 MDMA-assisted therapy for severe PTSD https://t.co/R0DH1wTrlF
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/2T8FcvlVbj
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/NUBuL1NWDJ
RT @REMAPTherapy: Happy New Year! #4 in our year-end Psychedelic Research Review is the massive elephant in the room, "MDMA-assisted therap…
Happy New Year! #4 in our year-end Psychedelic Research Review is the massive elephant in the room, "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study", published in May @NatureMedicine. If not for @MAPS..?https://t.co/Yn2QvAGfhI
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/PN3fFwKa5R
In 2017, Breakthrough Therapy Status was awarded for Phase III The data from the first part of the study was published in Nature Medicine https://t.co/RDjgU5j0VM
トラウマ焦点化心理療法を行いつつ、MDMAを補助的に投与すると、プラセボ群に比べて有意に改善がみられた https://t.co/42XadzKJCW 重度PTSDへのMDMA補助療法: 無作為, 二重盲検, プラセボ対照第3相試験
Amazing discoveries! #psychedelic #medicine #science #human #complexity #heartandsoul MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/K6sT0Ao3lY
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/5u9nSOXxfG
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/k08hIeb4CT
@txsnipergirl https://t.co/FzIkvJGndI
#Research reading: MDMA-assisted therapy for severe #PTSD: a randomized, double-blind, placebo-controlled phase 3 study - https://t.co/8wkm7rnRdT
#Research reading: MDMA-assisted therapy for severe #PTSD: a randomized, double-blind, placebo-controlled phase 3 study - https://t.co/6aSu8qGxk2
El modo de acción de la MDMA difiere de los psicodélicos, pero también aumenta la serotonina en el cerebro. Ensayo fase III. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/T6zhHZolim
The future will be here before you know it. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/04FcR9O4DH
RT @nanome_inc: In this video, we explore how #phenethylamines such as #MDMA and #methamphetamine bind to transporter #proteins such as #se…
RT @nanome_inc: In this video, we explore how #phenethylamines such as #MDMA and #methamphetamine bind to transporter #proteins such as #se…
RT @nanome_inc: In this video, we explore how #phenethylamines such as #MDMA and #methamphetamine bind to transporter #proteins such as #se…
RT @nanome_inc: In this video, we explore how #phenethylamines such as #MDMA and #methamphetamine bind to transporter #proteins such as #se…
RT @nanome_inc: In this video, we explore how #phenethylamines such as #MDMA and #methamphetamine bind to transporter #proteins such as #se…
In this video, we explore how #phenethylamines such as #MDMA and #methamphetamine bind to transporter #proteins such as #serotonin transporter protein. https://t.co/N9TXxFBOpg #drugdesign #drugdiscovery #structuralbiology #medchem #compchem #virtualreality #vr #molecularbiology https://t.co/sk5VSAvgrx
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/oj51R8jCxY
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/KsQaS56Llw
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/DWKkoPdxyP
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/AtecFRpAJP
Η Έρευνα του προηγούμενου tweet μας / The research of our last tweet: Mitchell, J.M., Bogenschutz, M., Lilienstein, A. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med 27, 1025–1033 (2021) https://t.co/sWzM8cG0ry
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/pbibfSX4SA https://t.co/kccYrxHyLk
@therealbrom Impossible to pick just 3! https://t.co/3IkTnvKzrY https://t.co/lWM0E60y48 https://t.co/PJlNzmt8Az https://t.co/j7ZyOACT5U
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/aYMNV9FlU9
RT @metric_guru: and applying it to soldiers who face some of the most extreme and violent situations of human experience; it's irresponsib…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XxaIczfvuX https://t.co/5ElrBmhCnY
and applying it to soldiers who face some of the most extreme and violent situations of human experience; it's irresponsible, even cruel. Evidence-based interventions include CBT and even the soon-to-be approved MDMA-assisted therapy. (3/3) https://t.co/bUwBjpthg9
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/x3AgAZ3qGj
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study [Mitchell, J.M., Bogenschutz, M., Lilienstein, A. et al. Nat Med (2021). doi: 10.1038/s41591-021-01336-3] https://t.co/oFrlVe1Nke https://t.co/9bhqbQFnti
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XxaIczx6mv https://t.co/QaVUmPPp1n
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/R1CCzxe0y9
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/qkEhWL5RXU #clinicaltrials https://t.co/L8JZm58uf8
RT @Prison_Health: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XxaIczf…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XxaIczfvuX https://t.co/a4xbdAzFnU
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study: https://t.co/Ll1GsollUw
RT @UpToPhate: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/ZpR9oLaGrY
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/ZpR9oLaGrY
This is extremely promising. “MDMA-assisted therapy is highly efficacious in individuals with severe PTSD, and treatment is safe and well-tolerated” MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/DCCPd6viRS
RT @LukeJelen: #MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XDkB7aNYiB…
RT @ExpertWitness_: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study Post-traumatic str…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. https://t.co/LQoQbjykLc
RT @RutgersTox: #ATEAMTox Journal club: Presented by Nick Husak @nph_pharmD @MDPoisonCtr @NJPoisonCenter @ChildrensPhila https://t.co/tkbBW…
RT @PsydelicsToday: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/iNMUF6…
RT @RutgersTox: #ATEAMTox Journal club: Presented by Nick Husak @nph_pharmD @MDPoisonCtr @NJPoisonCenter @ChildrensPhila https://t.co/tkbBW…
#ATEAMTox Journal club: Presented by Nick Husak @nph_pharmD @MDPoisonCtr @NJPoisonCenter @ChildrensPhila https://t.co/tkbBWLa4jM
RT @ichiipsy: 重度のPTSD患者に対するサイケデリック療法 としてのMDMA支援療法の有効性、安全性を調べた第III相二重盲検比較試験によれば、MDMA支援療法はトラウマやうつ気分などの病状の改善に有効かつ、暴力のリスクや自殺、その他の有害事象とも関連しなかったそ…
RT @PsydelicsToday: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/iNMUF6…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/iNMUF6kSMv
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/QAjMyJmUFp
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/TtD2RA2A5X
Although we can't beat the graphics provided in the notes by MAPS themselves, here are our observations on this study https://t.co/RDjgU5j0VM
RT @sminaev2015: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine http…
RT @ichiipsy: 重度のPTSD患者に対するサイケデリック療法 としてのMDMA支援療法の有効性、安全性を調べた第III相二重盲検比較試験によれば、MDMA支援療法はトラウマやうつ気分などの病状の改善に有効かつ、暴力のリスクや自殺、その他の有害事象とも関連しなかったそ…
RT @ichiipsy: 重度のPTSD患者に対するサイケデリック療法 としてのMDMA支援療法の有効性、安全性を調べた第III相二重盲検比較試験によれば、MDMA支援療法はトラウマやうつ気分などの病状の改善に有効かつ、暴力のリスクや自殺、その他の有害事象とも関連しなかったそ…
重度のPTSD患者に対するサイケデリック療法 としてのMDMA支援療法の有効性、安全性を調べた第III相二重盲検比較試験によれば、MDMA支援療法はトラウマやうつ気分などの病状の改善に有効かつ、暴力のリスクや自殺、その他の有害事象とも関連しなかったそうだ Nat Med (2021). https://t.co/R0DH1wSTw7
RT @LukeJelen: #MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XDkB7aNYiB…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/TZ73IMCaVJ
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | 67% no longer qualified for a ptsd diagnosis! https://t.co/pYYhkvbXCy
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/9dtAr00AY1
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/OxHJo1bDMu
RT @PsilocybinAlpha: MAPS' Phase 3 MDMA-assisted therapy for PTSD Published in Nature Medicine "MDMA-assisted therapy for severe PTSD: a…
RT @LukeJelen: #MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XDkB7aNYiB…
This is huge. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine https://t.co/EAproy52qJ
Huge news! Great results on MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/IAoSiqyrsr
RT @arnthorjon: "We conclude that #MDMA-assisted therapy represents a potential breakthrough treatment that merits expedited clinical evalu…
RT @LukeJelen: #MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XDkB7aNYiB…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study - Author: Annapurna__ - Link: https://t.co/0CrV32FUAM https://t.co/yPP1V3EFbJ
RT @PsilocybinAlpha: MAPS' Phase 3 MDMA-assisted therapy for PTSD Published in Nature Medicine "MDMA-assisted therapy for severe PTSD: a…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/MLtsf24F4S
RT @LukeJelen: #MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study https://t.co/XDkB7aNYiB…
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study - https://t.co/kMncNVQDFy
RT @arnthorjon: "We conclude that #MDMA-assisted therapy represents a potential breakthrough treatment that merits expedited clinical evalu…
RT @arnthorjon: "We conclude that #MDMA-assisted therapy represents a potential breakthrough treatment that merits expedited clinical evalu…